A $62 million settlement is easier to absorb when insurance picks up the entire bill — but the disclosure failures that triggered this class action have already done their work, reshaping how institutional investors read guidance from A2 Milk and its listed FMCG peers.
The A2 Milk Company has reached an in-principle agreement to settle the consolidated shareholder class action arising from its FY21 guidance disclosures. The settlement sum of $62 million, inclusive of interest and costs, will be met in full by available insurance proceeds and will not affect FY26 earnings. The company has not admitted liability, and the agreement remains subject to formal court approval.
What Is a Shareholder Class Action and Why It Matters for FMCG
Shareholder class actions are a formal mechanism through which groups of investors collectively pursue compensation for losses they allege were caused by a company’s misleading conduct or failure to meet continuous disclosure obligations. In Australia, those obligations require ASX-listed companies to immediately disclose any information that a reasonable person would expect to materially affect their share price.
For FMCG companies with dual listings — in A2 Milk’s case, the ASX and NZX — the compliance obligation effectively doubles, applying under both Australian and New Zealand law. When a company’s sales forecasts prove materially wrong and shareholders claim they were not warned promptly, the gap between guidance and reality becomes the legal battleground.
A2 Milk’s FY21 situation illustrated exactly this dynamic. The company had been riding strong pandemic-era demand for infant formula in China, only to face a rapid deterioration in sales driven by changing retail channels and a disrupted daigou trade. The speed and scale of that reversal put the adequacy of its forward guidance disclosures under significant scrutiny.
A2 Milk’s $62 Million Settlement: What the Agreement Covers
Two separate class action proceedings were filed against A2 Milk in October and November 2021, both on behalf of shareholders who held fully paid ordinary shares between 19 August 2020 and 9 May 2021. The proceedings were brought by Slater and Gordon and Shine Lawyers and were consolidated into a single action in 2022.
The claims alleged that A2 Milk made misleading representations and failed to meet its continuous disclosure obligations under Australian and New Zealand securities law, specifically in relation to its guidance and disclosures for the FY21 financial year.
The company confirmed the $62 million settlement amount covers interest and legal costs in full. Critically, A2 Milk confirmed the full amount will be funded by existing insurance proceeds, meaning no direct earnings impact in FY26. The company was explicit that it does not admit liability as part of this agreement.
Emma Pelka-Caven, head of class actions at Slater and Gordon, described the in-principle settlement as an important step in proceedings and confirmed that more than 70 per cent of the settlement sum — over $43 million — will be distributed to group members if court approval is obtained. Jonathan Wertheim, practice leader at Shine Lawyers, said the outcome represents a fair resolution and avoids the delay and uncertainty of a lengthy trial.
How the Settlement Distribution Is Structured
The in-principle nature of the agreement means it is not yet final. A deed of settlement must be executed, after which the Supreme Court of Victoria will need to formally approve the outcome before any funds are distributed to eligible shareholders.
We are watching the distribution structure closely, because the majority of the settlement sum going to group members — rather than being absorbed by legal costs — is precisely the benchmark courts scrutinise when assessing whether a class action outcome is genuinely fair.
| Item | Detail |
|---|---|
| Total settlement amount | $62 million (inclusive of interest and costs) |
| Funding source | Available insurance proceeds |
| FY26 earnings impact | None confirmed |
| Share of settlement to group members | More than 70 per cent |
| Shareholder eligibility window | 19 August 2020 – 9 May 2021 |
| Court approval required | Supreme Court of Victoria |
| Liability admission | None — company explicitly did not admit liability |
| Lead law firms | Slater and Gordon; Shine Lawyers |
What This Settlement Does Not Resolve
An in-principle agreement is not a finalised outcome. Until the Supreme Court of Victoria formally approves the deed of settlement, the matter remains legally open. Court approval of class action settlements in Australia can take several months and occasionally attracts objections from group members who dispute the distribution terms.
The settlement also does not resolve A2 Milk’s underlying commercial headwinds. The company has separately flagged that China’s falling birth rate continues to weigh on infant formula volumes — a structural challenge that no legal resolution addresses. The reputational signal attached to a disclosure-related class action, even one settled without admission of liability, persists in institutional investor memory.
Smaller FMCG companies without comparable insurance coverage would face a very different financial equation confronting a similar claim — a point worth noting as class action activity in the consumer goods sector continues to grow.
Who Stands to Benefit and on What Timeline
Eligible shareholders who held A2 Milk shares during the defined period stand to receive the largest share of the settlement. Legal teams at both Slater and Gordon and Shine Lawyers will manage the distribution process once court approval is secured, with the timeline dependent on how quickly the deed is executed and the Victorian Supreme Court schedules its approval hearing. For A2 Milk’s current shareholders and management, the more immediate benefit is the removal of multi-year litigation uncertainty from the company’s risk register.
Continuous Disclosure Obligations Across FMCG Are Being Tested
A2 Milk’s settlement lands at a moment when continuous disclosure obligations are receiving heightened attention across ASX-listed consumer goods companies. Regulatory expectations around forward guidance — particularly during periods of rapid channel or demand disruption — have tightened since A2 Milk’s FY21 episode. The Australian Securities and Investments Commission (ASIC) has signalled ongoing interest in how listed companies manage their disclosure obligations when market conditions shift quickly and materially.
For FMCG brands operating in volatile categories — infant formula, health supplements, and products heavily exposed to cross-border retail channels — the lesson from this case is structural. Guidance issued during periods of rapid channel change carries outsized legal risk if the company is slow to revise it publicly. Boards and chief financial officers across the sector are watching this settlement closely, not because $62 million is catastrophic for a company of A2 Milk’s size, but because of what it confirms about investor expectations and legal exposure when forecasts miss badly.
If you work in investor relations, compliance, or finance within a listed FMCG business, now is the time to review your forward guidance protocols against current ASIC guidance — this case has set a clear reference point for what courts and regulators consider acceptable disclosure practice.
With the Supreme Court of Victoria yet to formally approve the deed of settlement, the chapter is not quite closed — but once court approval lands, every listed FMCG company with a guidance miss on record will need to consider what this precedent means for their own exposure.